Skip to content

Change in Inventories at other companies

Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$4.14M+728%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$7.05M+121%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
-$338K+66.5%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
-$2.24M-1,043%
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
$909K
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
$3.09M+437%

Other financials

Income statement

See full
Revenue$214.3M+55.5%
Gross profit$193.5M+61.3%
Operating income$29.3M+121%
Net income$22.6M+165%
EPS (diluted)$0.27+145%

Balance sheet

See full
Cash & equivalents$190.0M+20.9%
Total debt$9.0M-9.0%
Total equity$605.7M+32.4%
Total assets$825.3M+37.7%

Cash flow

See full
Operating cash flow$50.2M+125%
CapEx$161.0K+62.6%
Free cash flow$50.0M+125%

Valuation

See full
Market cap$4.24B+128%
Enterprise value$4.06B+139%
P/E58×
P/S5.6×+1.8×

Profitability

See full
Gross margin89.3%+3.5pp
Operating margin12.4%+10.2pp
Net margin9.7%+7.6pp
FCF margin21.8%+12.2pp

Returns & leverage

See full
Return on equity13.7%+11.3pp
Debt / equity0.0×
Current ratio3.8×+0.1×

Where this comes from

Reported directly by Kiniksa Pharmaceuticals International, plc in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.

The official record: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kiniksa Pharmaceuticals International, plc's change in inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kiniksa Pharmaceuticals International, plc's change in inventories?
Kiniksa Pharmaceuticals International, plc (KNSA) reported change in inventories of $18.25M in Q1 2026.
How has Kiniksa Pharmaceuticals International, plc's change in inventories changed year-over-year?
Kiniksa Pharmaceuticals International, plc's change in inventories increased by 524.8% year-over-year, from -$4.3M to $18.25M.
What is the long-term trend for Kiniksa Pharmaceuticals International, plc's change in inventories?
Over 2 years (2021 to 2024), Kiniksa Pharmaceuticals International, plc's change in inventories has grown at a 13.8% compound annual growth rate (CAGR), from $3.68M to -$4.76M.
What does change in inventories mean?
Increase or decrease in inventory levels, directly affecting operating cash flow and working capital.